These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 15359858

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Hepatitis C and liver transplantation].
    Durand F.
    Gastroenterol Clin Biol; 2002 Apr; 26 Spec No 2():B82-90. PubMed ID: 12180312
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Clinical significance of measuring HCV-RNA levels in patients with chronic hepatitis C by IFN treatment, including combination therapy with ribavirin].
    Kakumu S.
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):507-10. PubMed ID: 15359851
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Hepatitis C is curable. Even slightly elevated liver enzymes need further examination].
    Niederau C.
    MMW Fortschr Med; 2008 Mar 27; 150(13):26. PubMed ID: 18522352
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Efficacy of and indications for IFN retreatment of patients with chronic hepatitis C].
    Iyoda K, Kato M.
    Nihon Rinsho; 2004 Jul 27; 62 Suppl 7(Pt 1):502-5. PubMed ID: 15359850
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A sustained virological response to interferon or interferon/ribavirin reduces hepatocellular carcinoma and improves survival in chronic hepatitis C: a nationwide, multicentre study in Taiwan.
    Yu ML, Lin SM, Chuang WL, Dai CY, Wang JH, Lu SN, Sheen IS, Chang WY, Lee CM, Liaw YF.
    Antivir Ther; 2006 Jul 27; 11(8):985-94. PubMed ID: 17302368
    [Abstract] [Full Text] [Related]

  • 17. The faster the better?
    Carulli N.
    Intern Emerg Med; 2006 Jul 27; 1(2):91-3. PubMed ID: 17111779
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Prevention of development of hepatocellular carcinoma from HCV-associated liver cirrhosis by multi-agents therapy including stronger-neo-minophagen C].
    Tarao K.
    Nihon Rinsho; 2001 Oct 27; 59 Suppl 6():769-73. PubMed ID: 11762054
    [No Abstract] [Full Text] [Related]

  • 20. [Management of patients with hepatitis C virus infection. Virological tests].
    Pawlotsky JM.
    Gastroenterol Clin Biol; 2002 Apr 27; 26 Spec No 2():B180-7. PubMed ID: 12180286
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.